The role of NKG2D in tumour immune surveillance is strongly supported by the fact that NKG2D-deficient mice are more susceptible to spontaneous tumour development in the TRAMP (transgenic adenocarcinoma of mouse prostate) and Eμ-myc lymphoma transgenic model systems [133]. Here, KLRK1 is linked to urogenital neoplasm.